Page 14 - Pfizer

Even a single vaccine dose cuts Covid-19 infection rate, new UK study finds

A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65%

Astrazeneca is yellow, Pfizer green: Hungary's Covid vaccine-themed treats

At a patisserie in the small town of Vere­segyhaz, the choice is between a selection of layered mousses with colourful jelly toppings, presented in small glasses, with decorative syringes on top

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

Expanding vaccine supply

Some good moves but freer pricing needed

From Sputnik V to Moderna, here's a snapshot of Covid-19 vaccines

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria

Another dose of vaccine likely to be needed with 12 months: Pfizer CEO

Pfizer Chief Executive Officer Albert Bourla said people will likely need a third dose of the Pfizer/BioNTech Covid-19 vaccine within 12 months of getting fully inoculated

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Many vaccine makers in talks with govt as India wants a portfolio of products

India fast-tracks emergency use of foreign-made Covid-19 vaccines

No need for prior local clinical trials for vaccines cleared by regulators

Right prescription

Fast-tracking of vaccine approvals is a welcome policy change

Nifty outlook and stock picks by Sameet Chavan: Buy Balrampur Chini, Pfizer

The deciding factor in days to come has to be the financial space

Pfizer asks US FDA to clear its coronavirus vaccine for use in kids

Pfizer and BioNTech have asked the US Food and Drug Administration (FDA) to expand the Emergency Use Authorization (EUA) for its Covid-19 vaccine to include children ages 12 to 15.

Pfizer asks US government to allow more kids to get Covid-19 vaccine

Drug giant Pfizer and its partner in developing the first COVID-19 vaccine that received emergency authorisation in the US want to allow more adolescents to receive the vaccine

Australia backs Pfizer virus vaccine over AstraZeneca for under-50s

Australia's Chief Medical Officer, Paul Kelly, told reporters the risk of clots was extremely low.

US begins study assessing allergic reactions to Pfizer, Moderna vaccines

Data from the study, which is sponsored and funded by the NIAID, is expected to be released in late summer

France imposes third lockdown amid rising Covid-19 cases, schools closed

The French leader implored the nation to make an extra effort as the lockdown comes into force on Saturday

Supply chain threats

Vaccine nationalism shows how the pandemic has stressed trade

Pfizer says its Covid-19 vaccine protects younger teens

Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group

Top headlines: PLI for food processing; RBI relief for auto-debit payments

Business Standard brings you top news of the day

BioNTech-Pfizer says its Covid-19 vaccine effective on 12-15 year olds

In a study of 2,260 U.S. volunteers ages 12 to 15, preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given dummy shots

BioNTech-Pfizer raise 2021 Covid-19 vaccine output goal to 2.5 bn doses

Pfizer previously said the partners would likely produce between 2.3 billion and 2.4 billion doses in 2021